Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
Obesity is a major but often overlooked driver of gynecologic and reproductive problems in women. From menstrual irregularities and infertility to pregnancy complications and menopausal symptoms, excess adiposity disrupts hormonal and metabolic balance across the lifespan. Clinicians are urged to treat obesity as a contributing factor — but never the sole explanation — and to pursue timely, comprehensive, patient-centered care.
Obesity isn't just a number on a scale — it's a metabolically active condition that can disrupt women's reproductive health at every stage of life. Excess adipose tissue promotes insulin resistance, chronic inflammation, and altered estrogen and androgen levels, contributing to conditions like menstrual irregularities, anovulation, infertility, polyendocrine metabolic ovarian syndrome (PMOS, formerly PCOS), abnormal uterine bleeding, and endometrial cancer. During pregnancy, obesity raises risks for gestational diabetes, hypertensive disorders, and cesarean delivery, while in menopause it can worsen metabolic decline and symptom burden.
Clinicians are encouraged to evaluate symptoms promptly and avoid attributing everything to weight alone. Effective obesity treatment — including lifestyle changes, metformin, GLP-1 medications, or bariatric surgery — can meaningfully improve ovulation, menstrual regularity, and fertility. Importantly, contraceptive counseling is essential, as fertility can return unexpectedly with treatment.
Key Takeaways:
Why it matters: Obesity affects millions of women, yet weight stigma can delay diagnosis and treatment of serious gynecologic conditions. A whole-patient approach — one that treats obesity as one piece of a complex picture, not the whole story — leads to better outcomes.
